Evaluation of Safety, Tolerability, and PK of VX15/2503 In Patients With MS

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2013
The purpose of this study is to evaluate the safety and tolerability of IV administration of VX15/2503 in patients with multiple sclerosis. The escalation part of the study will determine the maximum tolerated dose (MTD) or the Maximum Administered Dose if no MTD is found.
Epistemonikos ID: 600f247db533c0fae4a4a5c29e631fde28c32c0e
First added on: Mar 31, 2022